Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PROS1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PROS1 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of PROS1 mRNA | increases expression | 16788091
|
C430898 |
AGN 194204 |
AGN 194204 results in increased expression of PROS1 mRNA | increases expression | 16339527
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PROS1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PROS1 mRNA | increases expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA | decreases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PROS1 mRNA | affects expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of PROS1 mRNA | decreases expression | 16239168
|
D003035 |
Cobalt |
[tungsten carbide binds to Cobalt] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 20105288
|
D003276 |
Contraceptives, Oral |
Contraceptives, Oral results in decreased expression of PROS1 | decreases expression | 15185533
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PROS1 mRNA | decreases expression | 20106945
|
D017135 |
Desogestrel |
Desogestrel affects the expression of PROS1 protein | affects expression | 11442481
|
D002945 |
Cisplatin |
PROS1 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
C023635 |
dienogest |
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine affects the expression of PROS1 mRNA | affects expression | 16995903
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine affects the expression of PROS1 protein | affects expression | 16995903
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROS1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of PROS1 mRNA | increases expression | 19619570
|
C454300 |
estradiol valerate-dienogest |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212
|
D004966 |
Estrogens, Conjugated (USP) |
Estrogens, Conjugated (USP) results in decreased expression of PROS1 protein | decreases expression | 15850603
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROS1 protein | affects cotreatment|affects expression | 11720199
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 11994571
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 16522526
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROS1 | affects cotreatment|increases expression | 15669648
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 14551147
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of PROS1 protein | decreases expression | 17374706
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in decreased activity of PROS1 protein | decreases activity | 11994571 14551147
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in decreased expression of PROS1 protein | decreases expression | 12618251 10928463 15318540
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROS1 protein | affects cotreatment|affects expression | 11720199
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 11994571
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 16522526
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROS1 | affects cotreatment|increases expression | 15669648
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 14551147
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D020849 |
Raloxifene |
Raloxifene affects the expression of PROS1 protein | affects expression | 15850603
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of PROS1 protein | decreases expression | 16202731
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PROS1 protein | affects expression | 15850603
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROS1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PROS1 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PROS1 mRNA | decreases expression | 18796159
|
C002802 |
tungsten carbide |
[tungsten carbide binds to Cobalt] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 20105288
|
C002802 |
tungsten carbide |
tungsten carbide results in decreased expression of PROS1 mRNA | decreases expression | 20105288
|
D014812 |
Vitamin K |
Vitamin K affects the carboxylation of and affects the secretion of PROS1 protein | affects carboxylation|affects secretion | 10706868
|
D014859 |
Warfarin |
PROS1 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 19752777
|
D014859 |
Warfarin |
PROS1 protein affects the susceptibility to Warfarin | affects response to substance | 19752777
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.57 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.28 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.37 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.37 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.71 | 15814532 17670903 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.86 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.59 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
9.59 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.59 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.59 | 14692618 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
3.39 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.97 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.33 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.48 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.19 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.49 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.94 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.94 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.60 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.20 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.83 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Cobalt |
2.83 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.83 | 17261762 14630087 19861407 17018787 12948864 16675129 17289903 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.83 | 15572757 17595753 17893378 17952589 15758505 16837676 17049068 16912660 17440819 17261762 17242785 15775269 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.83 | 16873071 19011961 19059307 19189212 19487384 17242785 19410462 16202921 15565566 20135344 19288272 18351453 19289846 19155303 20544844 18855134 21138602 19142967 18425577 19084267 17440819 20065188 16273361 19066611 19115204 20005174 15668708 18984771 20390343 19221464 19244106 11161223 20859285 18629630 19103187 19189210 17261762 18815881 21152245 18821012 17049068 18997820 19200415 16818667 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.83 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.18 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.51 | 3786805 15700767 18705752 15721981 16097048 16227642 16011737 15673190 16192424 16124888 16050911 10355542 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
7.63 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.63 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.23 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.34 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
13.34 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
13.34 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
13.34 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.34 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.34 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vitamin K |
13.34 | 16328049 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.94 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
4.81 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
4.81 | 16033868 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.70 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.70 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.26 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.43 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.43 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.43 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.43 | 18566989 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.58 | 11061249 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.62 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.62 | 16919318 11677210 16105132 17110522 15861022 17681005 17333356 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
17.62 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.62 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 16354765 8697196 12621046 15668235 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.34 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.32 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.41 | 12872399 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.56 | 20497562 20579077 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.98 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.98 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.09 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.93 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
3.97 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.60 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
19.57 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
19.57 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
19.57 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
19.57 | 12644472 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.71 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.08 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.08 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.08 | 19336974 15027814 3732212 21278145 11566570 10915739 7120509 9327722 6884620 2869522 19085960 10092053 6623471 4309450 3786805 17522070 15998439 16227642 16177239 7440962 15968718 7179309 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
11.08 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.08 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.50 | 15033597 19839026 12231392 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.50 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.00 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
10.00 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.00 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.62 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.81 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
13.81 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
13.81 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.79 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.79 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.95 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.95 | 15464296 16481741 17638652 15173087 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
6.95 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
27.46 | 15959796 12795759 16239168 61145 17595544 12631006 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
27.46 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.46 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
27.46 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
27.46 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
27.46 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.07 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.90 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.12 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.12 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.12 | 20067830 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.43 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.69 | 12359135 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.94 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.53 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.06 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.19 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.18 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.35 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.37 | 20558911 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.43 | 17493413 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.14 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
9.67 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
9.67 | 18429757 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.33 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.35 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.35 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.75 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.37 | 16170182 16200630 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.47 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.25 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.94 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cobalt |
11.53 | 17039479 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.53 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.53 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.53 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.81 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.61 | 12359135 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.54 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.20 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.31 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.41 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.41 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.59 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.59 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.16 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.86 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
9.18 | 15190930 12231392 19839026 18289764 12649298 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.18 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.18 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
20.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
20.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
20.94 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.94 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
20.94 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.51 | 11231351 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.24 | 16973256 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.96 | 15342952 17567588 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.43 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.66 | 11408273 17174718 16943688 16221502 17157831 17334410 21278145 16239168 11903743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.24 | 14724832 17805973 18263696 15818738 18317297 18279442 18166357 14748882 12586293 17761835 12632512 17557913 15370692 18429990 12649538 12445421 12389079 17640975 15931870 12898905 15123356 18156304 15959796 18472332 20821823 15673190 15925388 18418968 18395095 15338365 12741479 17714472 12609069 10355542 18472094 18251166 18705752 12666154 17922224 17823541 12958196 17721639 15057751 15730626 18420326 18395914 15893842 18210741 11481614 12632514 17481882 16015684 16136751 14716496 17766677 16248980 17900296 12667390 17698563 12546737 14512876 12445418 14620537 18412020 18006644 17708605 18187930 17525996 14716833 18205269 16097048 15876570 17565644 18277467 17631135 18376398 16011737 16027843 16116963 13678700 17869086 18054572 15996030 18339082 16033810 16192424 15052691 15650968 15362042 17976157 17944888 16638106 18481824 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
8.24 | 15577212 16603200 17432682 15591649 15864749 18567088 15086199 14726149 15492853 15339415 15067225 12918455 17666798 15161499 17719030 15369754 17465448 14643895 16042886 15744066 15942678 15571005 16169303 16570917 15763062 17203207 17196135 12925901 18210741 15842777 17036385 17640959 18364076 15733078 14659978 18629640 16544323 17724770 15298665 15504291 15479170 15723089 14709902 14568256 17198567 16009107 17881167 16270385 15099470 15798949 17348192 15383259 18672772 17534399 18095165 17201889 16627068 18239293 18237412 18637143 15138612 18371158 15081153 15366600 15793283 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.24 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.24 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.24 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.02 | 16246199 16964402 15720792 15830285 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.89 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.04 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
9.04 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
16.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
16.56 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
16.56 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.56 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
16.56 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
12.71 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
12.71 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
12.71 | 6150874 1848544 15603536 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.71 | 12151625 |
MESH:D008173 |
Lung Diseases, Obstructive |
|
Cobalt |
5.59 | 6434250 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
4.60 | 17225452 6189445 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
4.60 | 16061637 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.60 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.60 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.48 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.38 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.38 | 19196723 11731420 16827153 19196722 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.70 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.70 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
3.31 | 12883367 16248763 15577323 17761969 18332650 17023156 12393984 16809738 18176117 12374674 11135225 16432458 18505091 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.31 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.58 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.58 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.13 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.50 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.27 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.24 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.23 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Contraceptives, Oral |
6.13 | 11752354 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.13 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.80 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.55 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.55 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.27 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
16.27 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
16.27 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
Warfarin |
16.27 | 14723717 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.44 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
4.65 | 16773208 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.65 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.72 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.45 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.21 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.05 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.58 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.58 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.31 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.42 | 8761367 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.08 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.08 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
7.28 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.28 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.97 | 17823083 15579764 17893378 15758505 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
4.70 | 15464296 6897625 17225452 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.70 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
2.90 | 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.43 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.04 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.06 | 17638057 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.35 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.99 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.91 | 11399792 11896295 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
2.18 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.18 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.18 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.18 | 15067354 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
6.07 | 18376272 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
9.07 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
9.07 | 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.13 | 16882103 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
6.07 | 19300499 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cobalt |
3.89 | 6434250 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.27 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.13 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.25 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.16 | 14601052 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.25 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.25 | 18551238 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.59 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.15 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.15 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.06 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.61 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.61 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.76 | 19457130 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.99 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.80 | 18396642 15958060 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
2.80 | 16033868 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.52 | 16837676 |
MESH:D020521 |
Stroke |
|
Warfarin |
8.52 | 19300499 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.37 | 17225452 15464296 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.88 | 16960144 18698879 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
23.97 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
23.97 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
23.97 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
23.97 | 17493413 |
OMIM:612336 |
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT |
marker/mechanism |
|
| |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
14.21 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
14.21 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
14.21 | 19300499 11307788 17245631 17672075 11518727 15720958 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.76 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.76 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.62 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.62 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
14.62 | 12973940 15464296 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
14.62 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.62 | 16712894 17572228 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.05 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.05 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
3.97 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.03 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.70 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.34 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
5.59 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
13.38 | 16837676 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
13.38 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
23.27 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
23.27 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
23.27 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
23.27 | 14723717 15733061 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.43 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.27 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.16 | 17120751 |